Characterization of patients with long-term responses to rucaparib treatment in recurrent ovarian cancer
Elizabeth M. Swisher, Rebecca Kristeleit, Amit M. Oza, Anna V. Tinker, Isabelle Ray‐Coquard, Ana Oaknin, Robert L. Coleman, Howard A. Burris, Carol Aghajanian, David M. O’Malley, Alexandra Léary, Stephen Welch, Diane Provencher, Geoffrey I. Shapiro, Lee-may Chen, Ronnie Shapira‐Frommer, Scott H. Kaufmann, Sandra Goble, Lara Maloney, Tanya T. Kwan, Kevin K. Lin, Iain A. McNeish
Topics & Concepts
MedicineInternal medicineLoss of heterozygosityOvarian cancerOncologyBRCA mutationGastroenterologyCancerPARP inhibitorPoly ADP ribose polymerasePolymeraseGeneticsGeneAlleleBiologyPARP inhibition in cancer therapyOvarian cancer diagnosis and treatmentBRCA gene mutations in cancer